The first data from the large implementation study of HIV pre-exposure prophylaxis (PrEP) in England, The IMPACT trial, were presented at the joint British HIV Association and British Association of Sexual Health and HIV conference this week. Chief Investigator, Dr Ann Sullivan of London’s Chelsea and Westminster Hospital, told the conference that although there were… Read More »
Headlines about COVID-19 vaccine and drug trial pauses may ring alarm bells for millions of people watching their progress, but FDA Commissioner Stephen Hahn, M.D., has another point of view. The breaks in the action actually show the development process is working as intended, Hahn told Bloomberg. “The system was designed to identify safety issues,” he… Read More »
UPDATE: The trial of the AZD1222 vaccine in the U.K. has already resumed after an independent investigation by the Medicines Health Regulatory Authority concluded it was safe to proceed. “AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials,” the company said in a September 12 press release.… Read More »
WEDNESDAY, June 3, 2020 — Hydroxychloroquine, the malaria drug touted and reportedly used by President Donald Trump as a preventative for COVID-19, appears not to have lived up to its hype, a new study shows. Unlike some prior studies, this new trial was a “gold standard” prospective, randomized clinical trial. It found that hydroxychloroquine could… Read More »